USPTO Grants Patent for Integrated Injection System and Communication Device

ChangeBridge: Patent Grants - Medical Devices (A61M)

Published March 24th, 2026

Detected March 25th, 2026

Summary

The USPTO has granted patent US12582351B2 to Becton Dickinson France S.A.S. for an integrated injection system that electronically connects an injection device with a communication device, such as a smartphone or reader. The system may include sensors to collect injection and patient data.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582351B2 to Becton Dickinson France S.A.S. The patent covers an integrated system for injection that combines an injection device with a communication device. This system allows for electronic connection, potentially enabling data transmission from sensors on the injection device to external devices like smartphones or dedicated readers. The patent specifies features such as a needle, drug delivery portion, data capture modules, and electronic chips or RFID tags for data recording and transmission.

This patent grant signifies a new technological development in the medical device sector, particularly for drug delivery systems. While not a regulatory rule, it indicates innovation in connected health devices. Companies in the pharmaceutical and medical device manufacturing sectors should be aware of this patented technology, as it may influence future product development and market offerings in connected injection systems. No immediate compliance actions are required for regulated entities based solely on this patent grant.

Source document (simplified)

← USPTO Patent Grants

Integrated injection system and communication device

Grant US12582351B2 Kind: B2 Mar 24, 2026

Assignee

Becton Dickinson France S.A.S.

Inventors

Christophe Bureau, Roderick Hausser, Hervé Monchoix

Abstract

An integrated system for injection including an injection device in electronic connection with a communication device is provided. The external communication device may be a handheld electronic device such as a Smartphone or a dedicated reader such as a reader capable of reading information contained on an RFID tag. The injection device includes a needle and a drug delivery portion enclosed within an external housing. Optionally, a plurality of sensors is affixed to the surface of the needle to collect data about the injection and physical characteristics of the patient. The data may be recorded on a data capture module. The electronic chip may be a readable and writable electronic chip such as a non-volatile memory chip. Alternatively, the electronic chip is a passive RFID tag. The injection device may further include a data transmitter for sending information obtained from the data capture module to the external communications device.